Rachel M Deacon

Summary

Publications

  1. doi Alprazolam use and related harm among opioid substitution treatment clients - 12 months follow up after regulatory rescheduling
    Rachel M Deacon
    Drug and Alcohol Services, South Eastern Sydney Local Health District, 591 South Dowling St, Surry Hills 2010, Australia Central Clinical School, University of Sydney, Sydney, NSW, Australia Electronic address
    Int J Drug Policy 36:104-11. 2016
  2. pmc Correlates of susceptibility to hepatitis B among people who inject drugs in Sydney, Australia
    Rachel M Deacon
    Sydney Medical School, The University of Sydney, Sydney, NSW, Australia
    J Urban Health 89:769-78. 2012
  3. doi At the intersection of marginalised identities: lesbian, gay, bisexual and transgender people's experiences of injecting drug use and hepatitis C seroconversion
    Rachel M Deacon
    The Kirby Institute, The University of New South Wales, Sydney, NSW, Australia
    Health Soc Care Community 21:402-10. 2013
  4. doi A randomised controlled trial of financial incentives to increase hepatitis B vaccination completion among people who inject drugs in Australia
    Libby Topp
    The Kirby Institute, University of New South Wales, NSW 2052, Australia
    Prev Med 57:297-303. 2013
  5. doi Feasibility of ambulatory withdrawal management delivered in a NSW drug health service and correlates of completion
    Rachel M Deacon
    Discipline of Addiction Medicine, Central Clinical School, Sydney Medical School, The University of Sydney, Drug Health Services, Level 6 KGV Building, Missenden Road, Royal Prince Alfred Hospital, Camperdown, NSW 2050, Australia Email
    Aust Health Rev 38:186-9. 2014

Detail Information

Publications5

  1. doi Alprazolam use and related harm among opioid substitution treatment clients - 12 months follow up after regulatory rescheduling
    Rachel M Deacon
    Drug and Alcohol Services, South Eastern Sydney Local Health District, 591 South Dowling St, Surry Hills 2010, Australia Central Clinical School, University of Sydney, Sydney, NSW, Australia Electronic address
    Int J Drug Policy 36:104-11. 2016
    ..We examine the effect of the rescheduling of alprazolam in Australia, from Schedule 4 to Schedule 8 in February 2014 amongst a high-risk population of clients in OST...
  2. pmc Correlates of susceptibility to hepatitis B among people who inject drugs in Sydney, Australia
    Rachel M Deacon
    Sydney Medical School, The University of Sydney, Sydney, NSW, Australia
    J Urban Health 89:769-78. 2012
    ..The lack of an association between incarceration and vaccination also suggests increasing vaccination uptake and completion in adult and juvenile correctional facilities may also be important...
  3. doi At the intersection of marginalised identities: lesbian, gay, bisexual and transgender people's experiences of injecting drug use and hepatitis C seroconversion
    Rachel M Deacon
    The Kirby Institute, The University of New South Wales, Sydney, NSW, Australia
    Health Soc Care Community 21:402-10. 2013
    ..Health professionals working in drug and HCV care services need to develop capacity in providing culturally appropriate health-care for LGBT PWID...
  4. doi A randomised controlled trial of financial incentives to increase hepatitis B vaccination completion among people who inject drugs in Australia
    Libby Topp
    The Kirby Institute, University of New South Wales, NSW 2052, Australia
    Prev Med 57:297-303. 2013
    ..This study aimed to investigate the efficacy of modest financial incentives in increasing completion of an accelerated 3-dose hepatitis B virus (HBV) vaccination schedule (0, 7, 21days) among people who inject drugs (PWID)...
  5. doi Feasibility of ambulatory withdrawal management delivered in a NSW drug health service and correlates of completion
    Rachel M Deacon
    Discipline of Addiction Medicine, Central Clinical School, Sydney Medical School, The University of Sydney, Drug Health Services, Level 6 KGV Building, Missenden Road, Royal Prince Alfred Hospital, Camperdown, NSW 2050, Australia Email
    Aust Health Rev 38:186-9. 2014
    ..The aim of the present study was to assess short-term ambulatory withdrawal management (AWM) outcomes at a drug health service (DHS) in Sydney, Australia, in the absence of specific funding...